Mazdutide
What is Mazdutide?
Innovent and Eli Lilly's investigational GLP-1 and glucagon dual agonist, developed principally for the Chinese market.
Not FDA-approved.
GLP Watchdog writes these definitions from FDA labels and peer-reviewed PubMed literature.
Where Mazdutide comes up on this site
On GLP Watchdog, Mazdutide comes up in 1 research article and 4 FDA warning letters. Browse the FDA warning letters.
Research that discusses it
Connected terms
Other terms under drug
Where the evidence lives
- The full GLP-1 glossary (150 terms, 8 categories)
- Research articles — written from primary sources
- Tools and calculators
- Compare GLP-1 telehealth providers